Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

Calvo Martínez, Lourdes

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/1518

PMID: 23733779

DOI: 10.1200/jco.2012.46.9841

ISSN: 0732-183X

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2013

Journal title

Journal Of Clinical Oncology

Type of content

Artigo